SLSN

Business Context and Reporting Period

Company: Nanophase Technologies Corporation (Note: Metadata listed "SOLESENCE, INC." but filing text confirms Nanophase Technologies Corporation).

Reporting Period: Quarterly period ended March 31, 1998 (Form 10-Q).

Business Overview: The Company develops and sells nanocrystalline materials. It transitioned from a development stage to full-scale commercial production in early 1997. The Company completed its Initial Public Offering (IPO) in December 1997, raising approximately $28.8 million in net proceeds.

Key Financial Metrics

Liquidity: Total cash, cash equivalents, and investments totaled approximately $30.5 million as of March 31, 1998. The Company has no long-term debt listed on the balance sheet.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 64% year-over-year, driven primarily by a 226% increase in product revenue ($636,734 vs. $195,136). This was partially offset by a 72% decrease in other revenue.
• Cost Efficiency: Cost of revenue decreased 12% despite higher sales volume, attributed to manufacturing efficiencies and reduced development costs. Gross margin improved significantly from a loss of 157% of revenue in 1997 to a loss of 38% in 1998.
• Operating Expenses: Selling, general, and administrative (SG&A) expenses increased 61% to $683,299, largely due to costs associated with becoming a public company and recruiting. R&D expenses increased 17% to $189,214.
• Interest Income: Interest income surged to $406,291 from $21,917, reflecting the investment of IPO proceeds in short-term securities.
• Net Loss Reduction: Net loss decreased by 29% to $887,400, aided by higher interest income and improved gross margins, though a $156,000 foreign tax provision was recorded.

Outlook, Risks, and Management Commentary

• Capital Resources: Management believes current cash and IPO proceeds are sufficient to fund operations for the foreseeable future. However, future capital requirements depend on R&D progress and manufacturing expansion.
• Future Spending: The Company expects to increase R&D and SG&A expenses for the remainder of 1998 to expand product lines, enhance manufacturing, and grow the sales force.
• Tax Position: The Company has a net operating loss carryforward of approximately $14 million and a foreign tax credit of $156,000. Utilization of the loss carryforward may be limited by ownership change rules under the Internal Revenue Code.
• Year 2000 Compliance: The Company assesses its risk as low, stating no significant software modifications are required. It relies on third-party systems but does not expect significant disruption.
• Risks: Key risks include customer acceptance of nanocrystalline materials, competitive technologies, and the potential need for dilutive financing if additional capital is required.

Investor Verification Checklist

• Revenue Quality: Verify the sustainability of the 226% increase in product revenue and the specific customer contracts driving this growth.
• Cash Burn Rate: Monitor the net cash used in operating activities ($177,829 for the quarter) to ensure the $30.5 million liquidity buffer remains adequate given planned expense increases.
• Foreign Tax Credit: Confirm the status of the $156,000 foreign tax credit and the likelihood of generating taxable income to utilize the $14 million NOL carryforward before expiration.
• Manufacturing Capacity: Assess the progress of the manufacturing facility expansion funded by the $219,522 in capital expenditures.
• Share Count: Note the significant increase in weighted average shares outstanding (from ~77k in 1997 to ~12.3M in 1998) due to the IPO, which impacts per-share metrics.